mevastatin has been researched along with Cardiac Remodeling, Ventricular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baurand, A; Bergmann, MW; Dietz, R; El Jamali, A; Freund, C; Rechner, C | 1 |
1 other study(ies) available for mevastatin and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Statins inhibit reoxygenation-induced cardiomyocyte apoptosis: role for glycogen synthase kinase 3beta and transcription factor beta-catenin.
Topics: Animals; Apoptosis; beta Catenin; Caspase 3; Caspases; Cell Hypoxia; Cell Line; Cytoskeletal Proteins; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lovastatin; Male; Myocardial Infarction; Myocytes, Cardiac; Pravastatin; Rats; Rats, Wistar; Trans-Activators; Ventricular Remodeling | 2004 |